What are the short-term effects of intravenous (IV) morphine?

Short-Term Effects of IV Morphine

IV morphine provides rapid pain relief within 1-2 minutes with peak effect at 3-5 minutes, lasting 3-4 hours, but carries significant risks of respiratory depression, sedation, nausea, and cardiovascular effects that require close monitoring. 1, 2

Therapeutic Effects

Analgesic Efficacy

• Onset of action: 1-2 minutes after IV administration 3, 4
• Peak effect: Achieved within 3-5 minutes 3
• Duration: 3-4 hours for immediate-release formulations 4, 5
• Pain relief: In opioid-naïve patients with severe cancer pain, 84% achieved satisfactory pain relief within 1 hour using 1.5 mg IV boluses every 10 minutes (median total dose 4.5 mg) 6, 4, 6

Dosing Parameters

For opioid-naïve adults 1, 2:

• Initial dose: 2-5 mg IV (or 0.1-0.2 mg/kg)
• Titration: Can repeat every 10-15 minutes until pain relief achieved
• Conversion ratio: IV to oral morphine is 1:3 (10 mg IV ≈ 30 mg oral) 1, 7

Adverse Effects

Respiratory Depression

This is the primary and most dangerous short-term risk 2:

• Occurs more frequently in elderly, debilitated patients, and those with compromised respiratory function
• Rapid IV administration may cause chest wall rigidity 2
• In one controlled study, 10 mg IV morphine caused only slight increases in PaCO2 (5.2 vs 4.8 kPa at 5 minutes) without severe respiratory depression when given to patients with moderate pain 8
• Critical: Naloxone and resuscitative equipment must be immediately available 2

Central Nervous System Effects

Common early effects that typically resolve within days 7:

• Sedation: Most prominent in first few days; patients in one study were slightly more sedated at 5-10 minutes post-IV versus IM administration 8
• Drowsiness, dizziness, mental clouding: Occur at treatment start but resolve when stabilized (usually within a few days) 7
• Dysphoric reactions: Can occur after any dose 2
• High-dose effects: Convulsions, toxic psychoses with high IV doses 2

Gastrointestinal Effects

• Nausea and vomiting: Occur in up to two-thirds of patients when morphine is started, but usually resolve 7
• Constipation: The main continuing adverse effect requiring prophylactic laxative use 7
• In hip fracture patients, IV morphine was associated with significantly higher gastrointestinal side effects (24% vs 10.5%) compared to other analgesics 9

Cardiovascular Effects

• Low doses: Minimal effect on cardiovascular stability 2
• High doses: Can cause sympathetic hyperactivity and increased catecholamines 2
• Hypotension: Particularly in patients with depleted blood volume, shock, or impaired myocardial function 2
• Orthostatic hypotension: Frequent complication in ambulatory patients receiving single-dose parenteral morphine 2
• In controlled studies, minimal changes in systolic blood pressure or pulse were observed 10

Other Short-Term Effects

• Histamine release: Flushing, diaphoresis, pruritus, wheals/urticaria at injection site 2
• Urinary retention: Oliguria and antidiuretic effect 2
• Pupillary changes: Miosis may obscure neurological assessment 2
• Temperature dysregulation: In susceptible individuals 2

Clinical Monitoring Requirements

Essential monitoring parameters immediately after IV administration 11:

• Respiratory rate and oxygen saturation
• Heart rate and blood pressure
• Sedation score
• Pain score
• Timing: At baseline, 10 minutes, and 20 minutes post-administration

Important Clinical Caveats

Contraindications 2

• Known hypersensitivity to morphine
• Respiratory depression without resuscitative equipment
• Acute or severe bronchial asthma or hypercarbia
• Paralytic ileus

High-Risk Populations Requiring Dose Reduction 1, 2

• Elderly or frail patients
• Renal insufficiency (morphine-6-glucuronide accumulation causes neurologic toxicity) 1
• Hepatic impairment
• Head injury or increased intracranial pressure
• Concurrent CNS depressants (alcohol, sedatives, benzodiazepines)

Drug Interactions

• CNS depressants: Increased risk of respiratory depression, hypotension, profound sedation 2
• MAOIs: Markedly potentiate morphine; require 14-day washout period 2
• Cimetidine: May precipitate apnea, confusion, muscle twitching 2

Comparative Context

IV morphine provides significantly faster pain relief than oral or IM routes 8:

• IV onset: 5 minutes vs IM onset: 20 minutes
• Between 5-25 minutes post-administration, IV morphine provided significantly better pain control than IM morphine
• However, by 24 hours, pain control was similar between routes

The short-term safety profile is acceptable when proper monitoring is in place, though the risk-benefit calculation must account for the serious potential for respiratory depression, particularly in vulnerable populations.